Tirzepatide, a novel medication, is creating considerable interest within the scientific community. It operates differently from common diabetes therapies , targeting multiple receptors involved in sugar regulation and hunger . Initial studies have demonstrated impressive efficacy in reducing blood glucose in individuals with diabetes of the second